Form 4 for MPT MEDICAL PROPERTIES TRUST INC
Accepted 2023-01-25 00:00:00 ET · period of report 2023-01-23 · accession 0001287865-23-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-25 | 2023-01-23+ | MPT | HAMNER R STEVEN | EVP, CFO, Dir | A - Grant | $0.00 | +559.8K | 2.09M | +37% | $0 |
| 2023-01-25 | 2023-01-25 | MPT | HAMNER R STEVEN | EVP, CFO, Dir | F - Tax | $11.14 | -95.0K | 2.40M | -4% | -$1.06M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2023-01-25 | A | A | 57,638 | $0.00 | 2,461,994 | D | — | — | (F3) Represents additional shares earned under the 2020 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement, adjusted pursuant to the modifier provisions in the award that were based on the Company's total return to shareholders. The shares vested in January 2023. |
| 2 | Common | Common stock, par value $0.001 | 2023-01-23 | A | A | 311,320 | $0.00 | 2,404,356 | D | — | — | (F2) Shares will be earned based on the achievement of specific performance thresholds pertaining to the Company's EBITDA and strategic transactions, as defined and set by our compensation committee, over the period from January 1, 2023 through December 31, 2025, with the opportunity to earn up to one third of the award for 2023 performance against the specified measures. The actual number of shares to be issued will vary depending upon the achievement of these specific performance thresholds and further adjusted pursuant to modifier provisions in the award that are based on the Company's total return to shareholders. |
| 3 | Common | Common stock, par value $0.001 | 2023-01-25 | F | D | 95,050 | $11.14 | 2,397,425 | D | — | — | (F5) Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. |
| 4 | Common | Common stock, par value $0.001 | 2023-01-25 | A | A | 30,481 | $0.00 | 2,492,475 | D | — | — | (F4) Represents additional shares earned under the 2022 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement, adjusted pursuant to the modifier provisions in the award that were based on the Company's total return to shareholders. The shares vested in January 2023. |
| 5 | Common | Common stock, par value $0.001 | 2023-01-23 | A | A | 160,378 | $0.00 | 2,093,036 | D | — | — | (F1) Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2023. |